The Gut-Vascular Axis in Intracranial Aneurysm Rupture: A Systematic Review and Meta-analysis of Human Microbiome Evidence

This systematic review and meta-analysis synthesizes human evidence to suggest that gut microbiome dysbiosis, characterized by reduced alpha diversity and specific microbial taxa alterations, is associated with intracranial aneurysm rupture and vascular inflammation, though further prospective research is needed to establish causality and clinical utility.

The Gist

Imagine your body is a bustling city. For a long time, doctors thought the "traffic jams" in your brain's blood vessels (aneurysms) were caused only by things like high blood pressure, smoking, or bad genes. They thought the city's plumbing was just wearing out on its own.

But this new research suggests there's a hidden mayor running the show from a completely different part of the city: your gut.

Here is the story of this paper, told simply:

The Gut-Brain Highway

Think of your gut (stomach and intestines) as a massive factory that produces chemicals and manages your city's immune system. It talks to your brain and your blood vessels through a super-highway called the Gut-Vascular Axis.

Usually, this factory is run by trillions of tiny workers called bacteria (your microbiome). When these workers are diverse and happy, they produce "peace treaties" (chemicals called Short-Chain Fatty Acids) that keep your blood vessel walls strong and calm.

The Problem: A Factory Strike

This study looked at what happens when the factory goes on strike. This is called dysbiosis (a fancy word for a bad bacterial balance).

The researchers found that people whose brain aneurysms burst (rupture) had a very different gut factory compared to healthy people or people with aneurysms that hadn't burst yet.

• The Diversity Drop: Imagine a forest with hundreds of different types of trees. In healthy people, the forest is lush and diverse. In people with ruptured aneurysms, the forest was like a monoculture farm—very few types of trees left. The study found that gut diversity was significantly lower in people who had a brain bleed.
• The Bad Workers: The "good" bacteria that make the peace treaties (like Faecalibacterium) were missing. Instead, "bad" bacteria that cause inflammation (like Campylobacter or E. coli) were taking over the factory.

The Evidence: Two Ways of Looking

The researchers didn't just guess; they looked at two different types of evidence:

1. The Direct Look (Observational Studies): They took stool samples from real patients. They saw that the patients with ruptured aneurysms had "messier" guts with less variety and more inflammation-causing bacteria. It's like finding a city with a lot of trash and smoke coming from the factory, right before the bridge collapses.
2. The Genetic Crystal Ball (Mendelian Randomization): This is a clever trick. Since you can't change a person's gut bacteria easily, the researchers looked at their DNA. Some people are genetically programmed to have more of certain "good" bacteria. The study found that people genetically predisposed to have more of specific bacteria (like Ruminococcus1 and Bilophila) were less likely to have aneurysms. This suggests the bacteria aren't just a side effect; they might actually be protecting the brain vessels.

The "Smoking Gun"

In a few cases, researchers even found bacterial DNA inside the actual walls of the burst aneurysms. It's as if the bad bacteria from the gut factory didn't just send angry letters; they physically broke into the city's plumbing and started a fire, weakening the walls until they burst.

What Does This Mean for You?

This is a game-changer because it turns a scary, unpredictable event into something we might be able to manage.

• The Gut is a Warning Sign: If we can test a person's gut bacteria, we might be able to predict who is at high risk of an aneurysm bursting before it happens.
• A New Way to Fix It: We can't easily change our genes, but we can change our gut! By eating more fiber (which feeds the good bacteria), taking probiotics, or avoiding unnecessary antibiotics, we might be able to "rebuild the factory." This could strengthen the blood vessel walls and prevent the rupture.

The Catch

The authors are careful to say: "We found a strong link, but we need more proof." The studies were small, and the data was a bit messy (like trying to solve a puzzle with some missing pieces). We need bigger studies to confirm exactly how to fix the gut to save the brain.

The Bottom Line

Your brain and your gut are best friends. If your gut is in chaos, your brain's blood vessels might be in danger. This paper suggests that fixing your gut health might be the key to keeping your brain safe, turning a complex medical mystery into a simple message: Eat well, feed your good bacteria, and protect your brain.

Technical Summary

1. Problem Statement

Intracranial aneurysm (IA) rupture is the primary cause of spontaneous subarachnoid hemorrhage (SAH), leading to high mortality and long-term neurological disability. While traditional risk factors (hypertension, smoking, genetics) are well-established, the mechanisms driving the transition from an unruptured to a ruptured state remain incompletely understood. Emerging evidence suggests a "gut-vascular axis," where gut microbiome dysbiosis influences vascular inflammation and endothelial integrity. However, existing human evidence linking specific gut microbial alterations to IA formation or rupture is fragmented, inconsistent, and lacks quantitative synthesis. This study aims to fill this gap by systematically evaluating human evidence regarding the association between gut microbiome alterations and intracranial aneurysm outcomes.

2. Methodology

The study adhered to PRISMA 2020 guidelines and was prospectively registered in PROSPERO (CRD420261360785).

• Search Strategy: A comprehensive search was conducted across PubMed, Scopus, Web of Science, Embase, and Cochrane CENTRAL from inception to April 1, 2026. Grey literature (preprints, clinical trials) was also screened.
• Eligibility Criteria:
  • Included: Observational human studies (cohort, case-control, cross-sectional) and Mendelian Randomization (MR) studies investigating gut microbiome characteristics (16S rRNA, shotgun metagenomics, metabolomics) in patients with diagnosed IAs (ruptured or unruptured).
  • Excluded: Animal studies, case reports (<10 patients), reviews, and studies lacking standard microbiome assessment or IA outcomes.
• Data Synthesis:
  • Alpha Diversity: A random-effects meta-analysis was performed using Standardized Mean Differences (SMD) to compare gut microbial alpha diversity between ruptured IA patients and controls. Data was extracted from 3 sequencing studies.
  • Mendelian Randomization (MR): Taxa reported in at least two independent MR studies were quantitatively synthesized using inverse-variance weighting of log-odds ratios to assess causal relationships.
  • Risk of Bias: Assessed using the Cochrane Quality in Prognosis Studies (QUIPS) tool across six domains.

3. Key Contributions

• First Quantitative Synthesis: This is the first meta-analysis to quantitatively pool human data on gut microbiome alpha diversity specifically in the context of intracranial aneurysm rupture.
• Integration of MR Evidence: It uniquely integrates observational clinical data with Mendelian Randomization analyses to distinguish between associative and potentially causal relationships between specific microbial taxa and aneurysm risk.
• Multi-Omics Perspective: The review synthesizes findings from 16S rRNA sequencing, shotgun metagenomics, and metabolomics, providing a holistic view of the gut-vascular axis.
• Identification of Protective Taxa: It identifies specific bacterial taxa (e.g., Ruminococcus1, Bilophila) that may exert protective effects against aneurysm rupture, offering potential therapeutic targets.

4. Key Results

Study Selection:

• Initial search yielded 396 records; 20 studies met inclusion criteria (12 observational clinical studies, 8 MR analyses).
• Total observational cohort size: ~1,580 IA patients and 450 controls.

Alpha Diversity Meta-Analysis:

• Finding: Patients with ruptured intracranial aneurysms demonstrated significantly reduced gut microbial alpha diversity compared to controls.
• Effect Size: Pooled SMD = −0.94 (95% CI: −1.31 to −0.57; p < 0.0001).
• Heterogeneity: Moderate heterogeneity observed (I² = 48.4%).
• Robustness: Sensitivity analyses (leave-one-out) confirmed the stability of the result; the association remained significant regardless of which study was excluded.

Mendelian Randomization (Causal Inference):

• Four microbial taxa were consistently identified across independent MR studies as having a protective causal association with aneurysm outcomes (reduced risk of formation/rupture):
  1. Ruminococcus1: Pooled OR = 0.49 (95% CI: 0.35–0.69)
  2. Bilophila: Pooled OR = 0.68 (95% CI: 0.55–0.85)
  3. Fusicatenibacter: Pooled OR = 0.65 (95% CI: 0.50–0.85)
  4. Porphyromonadaceae: Pooled OR = 0.65 (95% CI: 0.50–0.85)
• Heterogeneity among MR studies was negligible (I² = 0%).

Observational Findings (Taxonomic & Metabolic):

• Dysbiosis Patterns: Ruptured cases showed depletion of Short-Chain Fatty Acid (SCFA) producers (e.g., Faecalibacterium, Roseburia) and enrichment of pro-inflammatory taxa (e.g., Escherichia-Shigella, Campylobacter).
• Metabolites: Reduced levels of butyrate/propionate and elevated LPS-related metabolites were correlated with systemic inflammation and poor prognosis.
• Tissue Evidence: One study detected E. coli DNA in aneurysm wall tissue, suggesting potential bacterial translocation, though statistical significance was limited by sample size.

5. Significance and Implications

• Pathophysiological Insight: The findings support the "gut-vascular axis" hypothesis, suggesting that gut dysbiosis contributes to IA rupture through mechanisms involving reduced SCFA production, increased systemic inflammation, and endothelial dysfunction.
• Clinical Potential:
  • Biomarkers: Gut microbial signatures (specifically reduced alpha diversity and loss of SCFA producers) could serve as non-invasive biomarkers for risk stratification of aneurysm rupture.
  • Therapeutic Targets: The identification of protective taxa suggests that microbiome-targeted interventions (e.g., prebiotics, probiotics, dietary fiber enrichment, or fecal microbiota transplantation) could be explored as adjunctive strategies to stabilize aneurysms or prevent rupture.
• Limitations & Future Directions:
  • Current evidence is limited by small sample sizes, geographic heterogeneity, and a lack of longitudinal data to distinguish chronic dysbiosis from acute changes post-rupture.
  • Future research requires large, multicenter prospective cohorts with standardized sequencing, multi-omics integration (metabolomics + genomics), and randomized controlled trials to validate causal mechanisms and test microbiome-modulating therapies.

Conclusion:
This study provides the first quantitative evidence that gut microbiome dysbiosis, characterized by reduced alpha diversity and specific taxonomic shifts, is significantly associated with intracranial aneurysm rupture. It establishes a strong foundation for future translational research aimed at leveraging the gut microbiome for the prevention and management of this life-threatening condition.